BIO Ventures for Global Health
Katy M. Graef currently serves as the Vice President of Programs at BIO Ventures for Global Health. Katy M. has a strong background in virology research, having held various positions at the National Institutes of Health. Katy's expertise lies in molecular biology, cell biology, microscopy techniques, and analyzing scientific data. Katy M. holds a Ph.D. in Virology from the University of Oxford and a Bachelor of Science in Microbiology from the University of Washington. Their research experience includes studying viral determinants and structural proteins of tick-borne flaviviruses and the role of the influenza A virus PB2 protein in viral pathogenesis.
BIO Ventures for Global Health
BIO Ventures for Global Health (BVGH) is a Seattle-based nonprofit organization working at the crossroads of the private and public sectors to advance research and improve health. #BVGH #bvghAAI #AC3T BVGH connects people, resources, and ideas across biotechnology and pharmaceutical companies, governments, and nonprofits to solve global health issues. Programmatic activities include accelerating research and development (R&D) for diseases of poverty, expanding access to cancer medicines and technologies in Africa, and building biomedical R&D capacity in low- and middle-income countries (LMICs).